Inhibitors of prostate-specific membrane antigen in the diagnosis and therapy of metastatic prostate cancer – a review of patent literature

Preparation of the alpha-emitting prostate-specific membrane antigen targeted radioligand [212 Pb]Pb-NG001 for prostate cancer

(2020) Vilde Yuli Stenberg et al.   JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS

Impact of PSMA-targeted imaging with 18F-DCFPyL-PET/CT on clinical management of patients (pts) with biochemically recurrent (BCR) prostate cancer (PCa): Results from a phase III, prospective, multicenter study (CONDOR).

(2020) Michael J. Morris et al.   JOURNAL OF CLINICAL ONCOLOGY

Nonprostatic diseases on PSMA PET imaging: a spectrum of benign and malignant findings

(2020) Felipe de Galiza Barbosa et al.   CANCER IMAGING

Correction to: Randomized prospective phase III trial of 68Ga-PSMA-11 PET/CT molecular imaging for prostate cancer salvage radiotherapy planning [PSMA-SRT]

(2019) Jeremie Calais et al.   BMC CANCER

Dosimetry of 177Lu-PSMA-617 after Mannitol Infusion and Glutamate Tablet Administration: Preliminary Results of EUDRACT/RSO 2016-002732-32 IRST Protocol

(2019) Anna Sarnelli et al.   MOLECULES

PSMA-specific antitumor activity of a self-immolative tubulysin conjugate

(2019) Christopher P. Leamon et al.   BIOCONJUGATE CHEMISTRY

A novel 18F-labeled PSMA ligand for PET/CT imaging of prostate cancer patients: First-in-man observational study and clinical experience with 18F-JK-PSMA-7 during the first year of application

(2019) Felix Dietlein et al.   JOURNAL OF NUCLEAR MEDICINE

Synthesis and Preclinical Evaluation of Radio-Iodinated GRPR/PSMA Bispecific Heterodimers for the Theranostics Application in Prostate Cancer

(2019) Ayman Abouzayed et al.   Pharmaceutics

The effect of ligand amount, affinity and internalization on PSMA-targeted imaging and therapy: A simulation study using a PBPK model

(2019) Nusrat J. Begum et al.   Scientific Reports

Prostate Specific Membrane Antigen Targeted 18 F-DCFPyL Positron Emission Tomography/Computerized Tomography for the Preoperative Staging of High Risk Prostate Cancer: Results of a Prospective, Phase II, Single Center Study

(2018) Michael A. Gorin et al.   JOURNAL OF UROLOGY

[ 177 Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study

(2018) Michael S Hofman et al.   LANCET ONCOLOGY

Effects of Linker Modification on Tumor-to-Kidney Contrast of 68Ga-Labeled PSMA-Targeted Imaging Probes

(2018) Hsiou-Ting Kuo et al.   MOLECULAR PHARMACEUTICS

Monosodium glutamate reduces68Ga-PSMA-11 uptake in salivary glands and kidneys in preclinical prostate cancer model

(2018) Etienne Rousseau et al.   JOURNAL OF NUCLEAR MEDICINE

Reduction of 68Ga-PSMA renal uptake with mannitol infusion: preliminary results

(2017) Federica Matteucci et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

The Rise of PSMA Ligands for Diagnosis and Therapy of Prostate Cancer

(2016) A. Afshar-Oromieh et al.   JOURNAL OF NUCLEAR MEDICINE

Heterogeneous PSMA expression on circulating tumor cells - a potential basis for stratification and monitoring of PSMA-directed therapies in prostate cancer

(2016) Tobias M. Gorges et al.   Oncotarget

Design of Internalizing PSMA-specific Glu-ureido-based Radiotherapeuticals

(2016) Till Wüstemann et al.   Theranostics

PMPA for Nephroprotection in PSMA-Targeted Radionuclide Therapy of Prostate Cancer

(2015) C. Kratochwil et al.   JOURNAL OF NUCLEAR MEDICINE

Auger Radiopharmaceutical Therapy Targeting Prostate-Specific Membrane Antigen

(2015) A. P. Kiess et al.   JOURNAL OF NUCLEAR MEDICINE

Initial Evaluation of [18F]DCFPyL for Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer

(2015) Zsolt Szabo et al.   MOLECULAR IMAGING AND BIOLOGY

Heterobivalent Agents Targeting PSMA and Integrin-αvβ3

(2014) Hassan M. Shallal et al.   BIOCONJUGATE CHEMISTRY

68Ga-Complex Lipophilicity and the Targeting Property of a Urea-Based PSMA Inhibitor for PET Imaging

(2012) Matthias Eder et al.   BIOCONJUGATE CHEMISTRY

Prostate cancer targeting motifs: Expression of ανβ3, neurotensin receptor 1, prostate specific membrane antigen, and prostate stem cell antigen in human prostate cancer cell lines and xenografts

(2011) Robert M. Taylor et al.   PROSTATE